Navigation Links
Blindness can be stopped with drug for acne treatment

Stargardt's macular degeneration, also called juvenile macular degeneration, is an inherited disease which affects one in 10,000 people. This condition results from a defect in the ABCR gene, which is responsible for coding for a protein that removes all-trans-retinaldehyde, a vision byproduct, from retinal rods and cones. Rods and cones are supported by retinal-pigmented epithelium (RPE), a layer of cells near the retina. The accumulation of toxic pigments, or lipofuscin// results in the deterioration of the RPE leading to loss of rods and cones and subsequent central vision loss.

Researchers from the University of California, Los Angeles, have now found that Accutane, an acne treatment drug, stops the accumulation of lipofuscin in the eyes of mice with Stargardt's macular degeneration. Upon examination of the mice after two months of treatment with Accutane, the side effect of which includes night blindness, the researchers found no accumulation of toxins in the eyes. Gabriel Travis, M.D., suggested that the similarity of the mouse model with humans with Stargardt's makes it likely that Accutane will suppress lipofuscin from accumulating in Stargardt's patients.


'"/>




Page: 1

Related medicine news :

1. Smoking Linked to Blindness
2. Blindness may be genetic by nature
3. Enzyme Responsible For Congenital Blindness
4. Millions Of Diabetic And Glaucoma Patients Risk Blindness
5. Avastin, anti-Cancer Drug leads to Blindness and Other Complications
6. Genes That Were Responsible For The Cause Of Blindness Identified
7. Investigations Reveal That Infections Due To Contact lens Could Cause Blindness
8. Research into Blindness Cure Goes Digital
9. River Blindness Incidence Reduced With Effective Treatment
10. Blindness And Trachoma
11. Blindness cases in China on the rise
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance ... care insurance companies have a waiver for care if the client has a cognitive ... the family pays for care, is often waived, so the benefits from their insurance ...
(Date:10/13/2017)... Texas (PRWEB) , ... October 13, 2017 , ... Yisrayl ... this week that explains one of the most popular and least understood books in ... like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history ... The Brink” is the creation of published author, William Nowers. Captain Nowers and ... WWII veteran, he spent thirty years in the Navy. Following his career as ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... Israel and NEW YORK , Sept. 27, ... with mobile health and big data solutions, today announced that its MyDario ... Please check your local TV listings for when The Dr. Oz Show ... ... season this month. ...
(Date:9/23/2017)... Pa. , Sept. 22, 2017 Janssen ... a complete response letter from the U.S. Food and ... seeking approval of sirukumab for the treatment of moderately ... letter indicates additional clinical data are needed to further ... moderately to severely active RA. ...
(Date:9/19/2017)... Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses ... today:   ... Jim ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and business ...
Breaking Medicine Technology: